HYPOTHESIS AND THEORY article
Front. Vet. Sci.
Sec. Comparative and Clinical Medicine
Volume 12 - 2025 | doi: 10.3389/fvets.2025.1611850
Canine Sudden Acquired Retinal Degeneration Syndrome (SARDS) may be an Acquired Primary Ciliopathy, Phenotypically Similar to Human Alström and Bardet-Biedl Syndromes
Provisionally accepted- 1ClinPharmTox, LLC, Houston, United States
- 2Veterinary Ophthalmology Services, North Kingston, RI, United States
- 3Veterinary Medicine, University of Tennessee Medical Center, Knoxville, Tennessee, United States
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Sudden Acquired Retinal Degeneration Syndrome (SARDS) is an acquired canine disease that presents as a rapidly progressive retinal degeneration, often accompanied by polyphagia, weight gain, polydipsia, polyuria and hyposmia. Alström (AS) and Bardet-Biedl (BBS) Syndromes are rare human autosomal recessive genetic disorders marked by progressive retinopathy, polyphagia, obesity, polydipsia, polyuria and hyposmia with varying degrees of phenotypic severity. While the etiology of AS and BBS are partially understood, the cause of acquired SARDS has remained elusive. Historically, scientific inquiry has focused on an immunologic insult and/or endocrinopathy as the cause of SARDS. Clinicians have often pointed to these Cushingoid symptoms noted above in SARDS patients as evidence of a contributing endocrinopathy However, systemic cortisol concentrations pre-and post-ACTH stimulation typically do not differ appreciably between normal patients and those with SARDS. Blindness due to photoreceptor degeneration, and the observed Cushingoid symptoms, may be readily produced by dysfunctional or absent primary cilia, as documented in human AS and BBS. Recognition of SARDS as a possible acquired ciliopathy may be the first step in seeking effective treatments.
Keywords: SARDS, Retina, Systemic symptoms, ciliopathy, Vision, canine
Received: 14 Apr 2025; Accepted: 20 May 2025.
Copyright: © 2025 Toler, Abrams and Ward. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Steven Toler, ClinPharmTox, LLC, Houston, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.